NeuroPace Logo.png
NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance
June 03, 2021 07:00 ET | NeuroPace, Inc.
MOUNTAIN VIEW, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Logo.png
NeuroPace To Report First Quarter 2021 Financial Results on June 3, 2021
May 20, 2021 08:00 ET | NeuroPace, Inc.
MOUNTAIN VIEW, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy,...
NeuroPace Logo.png
NeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
April 26, 2021 16:05 ET | NeuroPace, Inc.
MOUNTAIN VIEW, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on developing products to treat and transform the lives of...
NeuroPace Logo.png
NeuroPace, Inc. Announces Pricing of Initial Public Offering
April 21, 2021 20:45 ET | NeuroPace, Inc.
MOUNTAIN VIEW, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on developing products to treat and transform the lives of...